Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Here is a specific, hour-by-hour action plan for the next 48 hours: Hour 1-2: Immediately assemble an emergency meeting with the executive team, including the Chief Medical Officer (CMO), Chief Scientific Officer (CSO), and General Counsel to discuss the situation and potential next steps.Read the full answer
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer